Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) - Total Assets
Based on the latest financial reports, Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) holds total assets worth CN¥2.92 Billion CNY (≈ $426.88 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Total Assets Trend (2011–2025)
This chart illustrates how Shanghai Haishun New Pharmaceutical Packaging Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Shanghai Haishun New Pharmaceutical Pack (300501) total market value for the company's overall valuation and market capitalisation.
Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Shanghai Haishun New Pharmaceutical Packaging Co Ltd's total assets of CN¥2.92 Billion consist of 43.7% current assets and 56.3% non-current assets. Review 300501 current and long-term liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 11.0% |
| Accounts Receivable | CN¥450.22 Million | 15.5% |
| Inventory | CN¥209.89 Million | 7.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥138.26 Million | 4.8% |
| Goodwill | CN¥20.98 Million | 0.7% |
Asset Composition Trend (2011–2025)
This chart illustrates how Shanghai Haishun New Pharmaceutical Packaging Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Shanghai Haishun New Pharmaceutical Pack stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Haishun New Pharmaceutical Packaging Co Ltd's current assets represent 43.7% of total assets in 2025, a decrease from 51.1% in 2011.
- Cash Position: Cash and equivalents constituted 11.0% of total assets in 2025, up from 9.4% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 8.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 15.5% of total assets.
Shanghai Haishun New Pharmaceutical Packaging Co Ltd Competitors by Total Assets
Key competitors of Shanghai Haishun New Pharmaceutical Packaging Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
PT Primadaya Plastisindo Tbk
JK:PDPP
|
Indonesia | Rp716.47 Billion |
|
SIG Combibloc Group AG
SW:SIGN
|
Switzerland | CHF7.07 Billion |
|
Suzhou Hycan Holdings Co Ltd
SHE:002787
|
China | CN¥2.98 Billion |
|
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
SHG:603976
|
China | CN¥1.95 Billion |
|
Orora Ltd
AU:ORA
|
Australia | AU$4.85 Billion |
|
Zhejiang Zhongcheng Packing Material Co Ltd
SHE:002522
|
China | CN¥3.54 Billion |
|
Rongsheng Paper
SHG:603165
|
China | CN¥4.73 Billion |
|
Great China Metal Industry Co Ltd
TW:9905
|
Taiwan | NT$11.53 Billion |
Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.66 | 2.67 | 1.26 |
| Quick Ratio | 2.18 | 2.15 | 0.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥815.03 Million | CN¥770.82 Million | CN¥123.95 Million |
Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shanghai Haishun New Pharmaceutical Packaging Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.33 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | 0.7% |
| Total Assets | CN¥2.91 Billion |
| Market Capitalization | $371.65 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Haishun New Pharmaceutical Packaging Co Ltd's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shanghai Haishun New Pharmaceutical Packaging Co Ltd's assets grew by 0.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shanghai Haishun New Pharmaceutical Packaging Co Ltd (2011–2025)
The table below shows the annual total assets of Shanghai Haishun New Pharmaceutical Packaging Co Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.91 Billion ≈ $425.37 Million |
+0.74% |
| 2024-12-31 | CN¥2.89 Billion ≈ $422.27 Million |
-3.38% |
| 2023-12-31 | CN¥2.99 Billion ≈ $437.03 Million |
+29.55% |
| 2022-12-31 | CN¥2.31 Billion ≈ $337.35 Million |
+1.82% |
| 2021-12-31 | CN¥2.26 Billion ≈ $331.30 Million |
+61.09% |
| 2020-12-31 | CN¥1.41 Billion ≈ $205.67 Million |
+13.82% |
| 2019-12-31 | CN¥1.23 Billion ≈ $180.70 Million |
+31.02% |
| 2018-12-31 | CN¥942.48 Million ≈ $137.91 Million |
+32.77% |
| 2017-12-31 | CN¥709.87 Million ≈ $103.88 Million |
+3.80% |
| 2016-12-31 | CN¥683.89 Million ≈ $100.08 Million |
+101.84% |
| 2015-12-31 | CN¥338.83 Million ≈ $49.58 Million |
+17.63% |
| 2014-12-31 | CN¥288.04 Million ≈ $42.15 Million |
+12.04% |
| 2013-12-31 | CN¥257.08 Million ≈ $37.62 Million |
+16.68% |
| 2012-12-31 | CN¥220.32 Million ≈ $32.24 Million |
+17.70% |
| 2011-12-31 | CN¥187.19 Million ≈ $27.39 Million |
-- |
About Shanghai Haishun New Pharmaceutical Packaging Co Ltd
HySum Flexibles Global, Inc. engages in the manufacture, sale, and export of pharmaceutical packaging products in China and internationally. The company offers pharmaceutical packaging products, including cold-form, tropical blister foil, PVC/Aclar sheets, PTP lidding, hipack child-resistant packaging, hipack AL/PE strip packs, hipack complex laminated flexible films, lamination foil and pouch, c… Read more